Pat Rayman
Impact in
- Immunology top 10%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 7
- Inflammatory Biomarkers in Disease Prognosis 2
- Cancer Cells and Metastasis 2
-
- Immune cells in cancer 6
- Inflammation biomarkers and pathways 2
- Immune Cell Function and Interaction 2
- Co-authors
- James H. Finke (10 shared papers)Peter A. Cohen (2 shared papers)Jennifer S. Ko (2 shared papers)Brian I. Rini (5 shared papers)Joanna Ireland (2 shared papers)Zeneng Wang (1 shared paper)Yvonne Parker (1 shared paper)Denise A. Hatala (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Photodiagnosis and Photodynamic Therapy (1 paper)The Journal of Immunology (1 paper)Molecular Immunology (1 paper)Clinical Genitourinary Cancer (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Pat Rayman
15 papers receiving 598 citations
Peers
Comparison fields: 5 of 66
- Immunology 242
- Cancer Research 164
- Oncology 204
- Pulmonary and Respiratory Medicine 94
- Molecular Biology 169
Countries citing papers authored by Pat Rayman
This map shows the geographic impact of Pat Rayman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pat Rayman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pat Rayman more than expected).
Fields of papers citing papers by Pat Rayman
This network shows the impact of papers produced by Pat Rayman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pat Rayman. The network helps show where Pat Rayman may publish in the future.
Co-authors
The 25 scholars most cited alongside Pat Rayman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 238 | |
| 2 | 2013 | 200 | |
| 3 | 2013 | 43 | |
| 4 | 2022 | 31 | |
| 5 | 2012 | 29 | |
| 6 | The Bcl-2 transgene protects T cells from renal cell carcinoma-mediated apoptosis. | 2003 | 15 |
| 7 | 1995 | 14 | |
| 8 | 2024 | 10 | |
| 9 | 2021 | 6 | |
| 10 | 2016 | 4 | |
| 11 | 2024 | 4 | |
| 12 | 2022 | 4 | |
| 13 | 2010 | 2 | |
| 14 | 2013 | 1 | |
| 15 | 2010 | 1 | |
| 16 | 2024 | 0 |
About Pat Rayman
Pat Rayman is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology, having authored 16 papers that have together received 602 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Immune cells in cancer (6 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), Renal cell carcinoma treatment (2 papers), Inflammation biomarkers and pathways (2 papers), Cancer Cells and Metastasis (2 papers), Immune Cell Function and Interaction (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Immunology (242 citations), Cancer Research (164 citations), Oncology (204 citations), Pulmonary and Respiratory Medicine (94 citations) and Molecular Biology (169 citations). Pat Rayman has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include James H. Finke, Peter A. Cohen, Jennifer S. Ko, Brian I. Rini, Joanna Ireland, Zeneng Wang, Yvonne Parker, Denise A. Hatala, Maryam Zamanian-Daryoush and Edward A. Fisher. Their work appears in journals such as Journal of Clinical Oncology, Photodiagnosis and Photodynamic Therapy, The Journal of Immunology, Molecular Immunology and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.